+ Author Affiliations Cannabinoids are a class of pharmacologic compounds that offer potential applications as antitumor drugs, based on the ability of some members of this class to limit inflammation, cell proliferation, and cell survival. In particular, emerging evidence suggests that agonists of cannabinoid receptors expressed by tumor cells may offer a novel strategy to treat cancer. Here, we review recent work that raises interest in the development and exploration of potent, nontoxic, and nonhabit forming cannabinoids for cancer therapy. [Cancer Res 2008;68(2):339–42] Cannabinoids for Cancer Treatment: Progress and Promise
Hasan Mukhtar, Department of Dermatology, University of Wisconsin-Madison, 1300, University Avenue, Medical Sciences Center, B-25, Madison, WI 53706. Phone: 608-263-3927; Fax: 608-263-5223; E-mail: hmukhtar@wisc.edu. Abstract
Footnotes
carolyn rose goyda
Missouri, USA
rosegojda@aol.com
"Clowns to the left of me, jokers to the right, Here I am, stuck in the middle ...." again
Stealers Wheel Album l
"The world is a dangerous place to live not because of the people who are evil, but because of the people who don't do anything about it." - Albert Einstein
"Injustice anywhere is a threat to justice everywhere." - Martin Luther King, Jr.
skip to main |
skip to sidebar
Pages
Saturday, August 14, 2010
[MedicalConspiracies] Cannabinoids for Cancer Treatment: Progress and Promise — Cancer Re
Blog Archive
- September 2024 (1)
- May 2024 (1)
- December 2021 (1)
- August 2021 (1)
- July 2021 (2)
- November 2020 (3)
- August 2020 (1)
- February 2020 (1)
- January 2020 (1)
- February 2019 (1)
- November 2018 (1)
- September 2018 (1)
- August 2018 (1)
- May 2018 (1)
- June 2017 (14)
- May 2017 (12)
- April 2017 (32)
- March 2017 (24)
- February 2017 (17)
- January 2017 (28)
- December 2016 (24)
- November 2016 (24)
- October 2016 (38)
- September 2016 (33)
- August 2016 (41)
- July 2016 (45)
- June 2016 (25)
- May 2016 (31)
- April 2016 (78)
- March 2016 (70)
- February 2016 (43)
- January 2016 (72)
- December 2015 (84)
- November 2015 (95)
- October 2015 (77)
- September 2015 (62)
- August 2015 (57)
- July 2015 (54)
- June 2015 (63)
- May 2015 (103)
- April 2015 (53)
- March 2015 (32)
- February 2015 (28)
- January 2015 (37)
- December 2014 (64)
- November 2014 (68)
- October 2014 (79)
- September 2014 (109)
- August 2014 (72)
- July 2014 (62)
- June 2014 (64)
- May 2014 (45)
- April 2014 (47)
- March 2014 (83)
- February 2014 (103)
- January 2014 (115)
- December 2013 (101)
- November 2013 (123)
- October 2013 (120)
- September 2013 (112)
- August 2013 (149)
- July 2013 (106)
- June 2013 (161)
- May 2013 (173)
- April 2013 (175)
- March 2013 (202)
- February 2013 (104)
- January 2013 (57)
- November 2012 (4)
- May 2012 (11)
- April 2012 (109)
- March 2012 (106)
- February 2012 (132)
- January 2012 (180)
- December 2011 (92)
- November 2011 (130)
- October 2011 (143)
- September 2011 (95)
- August 2011 (106)
- July 2011 (69)
- June 2011 (128)
- May 2011 (151)
- April 2011 (143)
- March 2011 (155)
- February 2011 (118)
- January 2011 (159)
- December 2010 (194)
- November 2010 (215)
- October 2010 (217)
- September 2010 (198)
- August 2010 (261)
- July 2010 (251)
- June 2010 (312)
- May 2010 (354)
- April 2010 (113)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.